Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients.
Tomita Y, Tatsugami K, Nakaigawa N, Osawa T, Oya M, Kanayama H, Nakayama Kondoh C, Sassa N, Nishimura K, Nozawa M, Masumori N, Miyoshi Y, Kuroda S, Tanaka S, Kimura A, Tamada S. Tomita Y, et al. Among authors: tatsugami k. Int J Urol. 2020 Nov;27(11):952-959. doi: 10.1111/iju.14329. Epub 2020 Aug 12. Int J Urol. 2020. PMID: 32789967 Free PMC article. Clinical Trial.
Laparoscopic adrenalectomy for malignant tumors.
Eto M, Hamaguchi M, Harano M, Yokomizo A, Tatsugami K, Naito S. Eto M, et al. Among authors: tatsugami k. Int J Urol. 2008 Apr;15(4):295-8. doi: 10.1111/j.1442-2042.2008.01997.x. Int J Urol. 2008. PMID: 18380814
Immunotherapy for renal cell carcinoma.
Itsumi M, Tatsugami K. Itsumi M, et al. Among authors: tatsugami k. Clin Dev Immunol. 2010;2010:284581. doi: 10.1155/2010/284581. Epub 2011 Jan 3. Clin Dev Immunol. 2010. PMID: 21253521 Free PMC article.
Exploring immune therapy for renal cancer.
Matsushita H, Kakimi K, Tomita Y, Tatsugami K, Naito S, Suekane S, Noguchi M, Moriya F, Matsuoka K, Itoh K, Kobayashi H, Eto M, Takahashi W, Kawano Y, Wada Y. Matsushita H, et al. Among authors: tatsugami k. Int J Urol. 2011 Jun;18(6):412-21. doi: 10.1111/j.1442-2042.2011.02762.x. Int J Urol. 2011. PMID: 21599759 No abstract available.
p300 mediates cellular resistance to doxorubicin in bladder cancer.
Takeuchi A, Shiota M, Tatsugami K, Yokomizo A, Tanaka S, Kuroiwa K, Eto M, Naito S. Takeuchi A, et al. Among authors: tatsugami k. Mol Med Rep. 2012 Jan;5(1):173-6. doi: 10.3892/mmr.2011.593. Epub 2011 Sep 20. Mol Med Rep. 2012. PMID: 21935574
152 results